Semaglutide 5mg 2mL dosage chart: a 2.5 mg/mL vial equals 10 units for 0.25 mg and 40 units for 1 mg on a U-100 syringe, plus a full titration table.
Semaglutide 5mg 2mL vials contain 2.5 mg of semaglutide per milliliter, so a 0.25 mg weekly starting dose equals 10 units and a 1 mg dose equals 40 units on a U-100 insulin syringe. The "5mg 2mL" on the label describes the entire vial, not a single dose, and that distinction is where most dosing confusion begins. Once you know the concentration, every other conversion is simple arithmetic.
What "5mg 2mL" Means on a Semaglutide Vial
The label is a total-strength statement. It says the vial holds 5 mg of semaglutide dissolved in 2 mL of liquid. To dose from it, you first convert that into a concentration.
5 mg ÷ 2 mL = 2.5 mg/mL.
- Total semaglutide in the vial: 5 mg
- Total volume: 2 mL
- Concentration: 2.5 mg per milliliter
- Total liquid in the vial: 200 units on a U-100 syringe
A U-100 insulin syringe is marked so that 1 mL equals 100 units. Any 2 mL vial, no matter what is inside it, holds 200 units of liquid.
Semaglutide 5mg 2mL Dosage Chart
The table below converts the standard weekly doses into volume and syringe units for a 2.5 mg/mL vial. Most people looking for a 5mg semaglutide dosing chart need exactly this conversion.
| Weekly dose | Volume to draw | Units on U-100 syringe | Doses per 2 mL vial |
|---|---|---|---|
| 0.25 mg | 0.10 mL | 10 units | 20 |
| 0.5 mg | 0.20 mL | 20 units | 10 |
| 1 mg | 0.40 mL | 40 units | 5 |
| 1.7 mg | 0.68 mL | 68 units | About 3 |
| 2.4 mg | 0.96 mL | 96 units | 2 |
Read the chart from left to right: the prescribed dose in milligrams, the volume that dose occupies, and the number of units you would draw. The final column shows how quickly a single vial is used up at each strength.
How to Convert mg to Units for Any Concentration
The formula works for any vial: units = (dose in mg ÷ concentration in mg/mL) × 100.
- Find your prescribed dose in milligrams.
- Divide it by the concentration printed on the vial.
- Multiply by 100 to get units on a U-100 syringe.
For a 2.5 mg/mL vial: 1 mg ÷ 2.5 mg/mL = 0.4 mL, and 0.4 mL × 100 = 40 units. If your vial is labeled 5 mg/mL instead, the semaglutide 5mg/ml dosage chart shows half those numbers, because 1 mg takes only 0.2 mL, or 20 units. Keeping the two charts separate helps prevent a double-dose mistake.
| Vial label | Concentration | Units for 0.25 mg | Units for 1 mg |
|---|---|---|---|
| 5 mg / 2 mL | 2.5 mg/mL | 10 units | 40 units |
| 5 mg / 1 mL | 5 mg/mL | 5 units | 20 units |
| 10 mg / 2 mL | 5 mg/mL | 5 units | 20 units |
| 2 mg / 1.5 mL | 1.33 mg/mL | About 19 units | About 75 units |
Two vials can hold the same total amount of drug and still require completely different syringe readings. That is why the concentration line always matters more than the total milligrams on the box.
Standard Semaglutide Titration Schedule
FDA-approved semaglutide products use a step-up schedule designed to limit gastrointestinal side effects. A typical progression looks like this:
- Weeks 1 to 4: 0.25 mg once weekly (10 units at 2.5 mg/mL)
- Weeks 5 to 8: 0.5 mg once weekly (20 units)
- Weeks 9 to 12: 1 mg once weekly (40 units)
- Weeks 13 to 16: 1.7 mg once weekly (68 units)
- Week 17 and beyond: 2.4 mg once weekly (96 units), the maximum approved maintenance dose
Not everyone advances to 2.4 mg. Many prescribers hold patients at 1 mg or 1.7 mg when blood sugar, weight, or side effects are already responding. At 2.4 mg per week, a 5 mg/2 mL vial lasts only about two weeks.
Practical Tips Before You Draw a Dose
- Recheck the concentration on the vial every time, since labels can change between refills.
- Use the syringe size your pharmacy provided; a U-100 syringe measures units, not milligrams.
- Do not double up after a missed week without asking your prescriber first.
- Follow the beyond-use date and storage instructions printed on the label.
What a Dosage Chart Cannot Tell You
A chart converts milligrams to units. It cannot tell you which dose is right for you, and it should never be used to self-adjust a prescription.
Compounded semaglutide is not FDA-approved for human use in the United States, and compounded products are not reviewed by the FDA for safety, effectiveness, or quality. The FDA-approved semaglutide products are Ozempic, Wegovy, and Rybelsus, each with its own labeled dosing.
Common side effects of semaglutide include nausea, vomiting, diarrhea, constipation, and abdominal pain. Seek medical attention for severe or persistent abdominal pain, signs of dehydration, or vision changes. Talk with a healthcare professional before changing doses or switching between products.
Why Concentration Math Matters for Other Vials
The 2.5 mg/mL calculation is not unique to semaglutide. Any vial labeled with a total mass and a total volume requires the same division before you draw a dose. People researching other compounds often keep separate references, such as a bpc-157 dosage chart by weight or a mots-c dosage chart, because the "total mg over total mL" confusion shows up everywhere.
The same math applies to a lipo-c peptide dosage chart, where several ingredients appear on one label and each has its own concentration. Dividing total milligrams by total milliliters is always the first step, and skipping it is the most common reason a measured dose does not match a prescription.
Frequently Asked Questions
How many units is 0.25 mg of semaglutide in a 5mg 2mL vial?
A 5mg 2mL vial has a concentration of 2.5 mg/mL. Drawing 0.25 mg means drawing 0.1 mL, which is 10 units on a U-100 insulin syringe. Always confirm the concentration printed on your own vial, because other 5 mg presentations use different total volumes.
How long does a semaglutide 5mg 2mL vial last?
It depends entirely on the dose. At 0.25 mg per week a 2 mL vial provides about 20 doses, at 1 mg it provides 5 doses, and at 2.4 mg per week it lasts only about two weeks. The beyond-use date from the pharmacy may expire before the vial is empty.
Is compounded semaglutide the same as Ozempic or Wegovy?
No. Compounded semaglutide is not FDA-approved for human use in the United States and is not reviewed by the FDA for safety, effectiveness, or quality the way Ozempic and Wegovy are. A licensed prescriber should decide whether an FDA-approved product or a compounded version is appropriate for you.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.